Skip to main content
Top
Published in: Clinical Rheumatology 7/2011

01-07-2011 | Original Article

Characteristics of chronic fatigue syndrome in a Japanese community population

Chronic fatigue syndrome in Japan

Authors: Masahide Hamaguchi, Yutaka Kawahito, Noriyuki Takeda, Takahiro Kato, Takao Kojima

Published in: Clinical Rheumatology | Issue 7/2011

Login to get access

Abstract

This study seeks to estimate the prevalence of chronic fatigue syndrome (CFS) and assess the characteristics of CFS in a community population in Japan using laboratory tests and questionnaires for lifestyle, fatigue states, and depression states. The design of this study is a cross-sectional observational study. The setting of this study is a medical health checkup program in a general hospital. This study was conducted with 1,430 Japanese (867 men and 563 women), 20 to 78 years of age. We classified participants who complained of fatigue according to the case definition of CFS proposed by the Centers for Disease Control and Prevention in the USA in 1994. Alcohol, caffeine, catechin and total polyphenol consumption, smoking status, sleep duration, and physical activity were evaluated using questionnaires. The prevalence of CFS was 1.0% (95% CI 0.5–1.6%) of a community population in Japan. Although various lifestyle factors of the participants with CFS were similar to those without chronic fatigue, average sleep duration was significantly shorter among the participants with CFS (5.5 ± 0.8 h) compared to those without chronic fatigue (6.3 ± 0.9 h, P < 0.001). Proportion at subjects having average sleep duration of less than 6 h was 64.3% among the participants with CFS in contrast to only 15.0% in those without chronic fatigue (P < 0.001). Among the eight case-defining symptoms, “Unrefreshing sleep” had high sensitivity and high specificity for screening CFS in Japanese population (92.9% and 87.8%, respectively). The average sleep duration was notably shorter in Japanese suffering from CFS. Further longitudinal study is needed to evaluate the possibility of extreme short sleep duration as a major cause of CFS in Japan.
Literature
1.
go back to reference Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A (1994) The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 121(12):953–959PubMed Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A (1994) The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 121(12):953–959PubMed
2.
go back to reference Holmes GP, Kaplan JE, Gantz NM et al (1988) Chronic fatigue syndrome: a working case definition. Ann Intern Med 108(3):387–389PubMed Holmes GP, Kaplan JE, Gantz NM et al (1988) Chronic fatigue syndrome: a working case definition. Ann Intern Med 108(3):387–389PubMed
3.
go back to reference Reeves WC, Heim C, Maloney EM et al (2006) Sleep characteristics of persons with chronic fatigue syndrome and non-fatigued controls: results from a population-based study. BMC Neurol 6:41PubMedCrossRef Reeves WC, Heim C, Maloney EM et al (2006) Sleep characteristics of persons with chronic fatigue syndrome and non-fatigued controls: results from a population-based study. BMC Neurol 6:41PubMedCrossRef
4.
go back to reference Van Hoof E, De Becker P, Lapp C, Cluydts R, De Meirleir K (2007) Defining the occurrence and influence of alpha-delta sleep in chronic fatigue syndrome. Am J Med Sci 333(2):78–84PubMedCrossRef Van Hoof E, De Becker P, Lapp C, Cluydts R, De Meirleir K (2007) Defining the occurrence and influence of alpha-delta sleep in chronic fatigue syndrome. Am J Med Sci 333(2):78–84PubMedCrossRef
5.
go back to reference Sharpley A, Clements A, Hawton K, Sharpe M (1997) Do patients with “pure” chronic fatigue syndrome (neurasthenia) have abnormal sleep? Psychosom Med 59(6):592–596PubMed Sharpley A, Clements A, Hawton K, Sharpe M (1997) Do patients with “pure” chronic fatigue syndrome (neurasthenia) have abnormal sleep? Psychosom Med 59(6):592–596PubMed
6.
go back to reference Reilly PA, Littlejohn GO (1990) Fibromyalgia and chronic fatigue syndrome. Curr Opin Rheumatol 2(2):282–290PubMedCrossRef Reilly PA, Littlejohn GO (1990) Fibromyalgia and chronic fatigue syndrome. Curr Opin Rheumatol 2(2):282–290PubMedCrossRef
7.
go back to reference Wong R, Lopaschuk G, Zhu G et al (1992) Skeletal muscle metabolism in the chronic fatigue syndrome. In vivo assessment by 31P nuclear magnetic resonance spectroscopy. Chest 102(6):1716–1722PubMedCrossRef Wong R, Lopaschuk G, Zhu G et al (1992) Skeletal muscle metabolism in the chronic fatigue syndrome. In vivo assessment by 31P nuclear magnetic resonance spectroscopy. Chest 102(6):1716–1722PubMedCrossRef
8.
go back to reference Bennett RM (1989) Confounding features of the fibromyalgia syndrome: a current perspective of differential diagnosis. J Rheumatol Suppl 19:58–61PubMed Bennett RM (1989) Confounding features of the fibromyalgia syndrome: a current perspective of differential diagnosis. J Rheumatol Suppl 19:58–61PubMed
9.
go back to reference Saggini R, Vecchiet J, Iezzi S et al (2006) Submaximal aerobic exercise with mechanical vibrations improves the functional status of patients with chronic fatigue syndrome. Eura Medicophys 42(2):97–102PubMed Saggini R, Vecchiet J, Iezzi S et al (2006) Submaximal aerobic exercise with mechanical vibrations improves the functional status of patients with chronic fatigue syndrome. Eura Medicophys 42(2):97–102PubMed
10.
go back to reference Riley MS, O’Brien CJ, McCluskey DR, Bell NP, Nicholls DP (1990) Aerobic work capacity in patients with chronic fatigue syndrome. BMJ 301(6758):953–956PubMedCrossRef Riley MS, O’Brien CJ, McCluskey DR, Bell NP, Nicholls DP (1990) Aerobic work capacity in patients with chronic fatigue syndrome. BMJ 301(6758):953–956PubMedCrossRef
11.
go back to reference Gibson H, Carroll N, Clague JE, Edwards RH (1993) Exercise performance and fatiguability in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 56(9):993–998PubMedCrossRef Gibson H, Carroll N, Clague JE, Edwards RH (1993) Exercise performance and fatiguability in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 56(9):993–998PubMedCrossRef
12.
go back to reference Lawrie SM, MacHale SM, Power MJ, Goodwin GM (1997) Is the chronic fatigue syndrome best understood as a primary disturbance of the sense of effort? Psychol Med 27(5):995–999PubMedCrossRef Lawrie SM, MacHale SM, Power MJ, Goodwin GM (1997) Is the chronic fatigue syndrome best understood as a primary disturbance of the sense of effort? Psychol Med 27(5):995–999PubMedCrossRef
13.
go back to reference LaManca JJ, Peckerman A, Walker J et al (1999) Cardiovascular response during head-up tilt in chronic fatigue syndrome. Clin Physiol 19(2):111–120PubMedCrossRef LaManca JJ, Peckerman A, Walker J et al (1999) Cardiovascular response during head-up tilt in chronic fatigue syndrome. Clin Physiol 19(2):111–120PubMedCrossRef
14.
go back to reference De Becker P, Roeykens J, Reynders M, McGregor N, De Meirleir K (2000) Exercise capacity in chronic fatigue syndrome. Arch Intern Med 160(21):3270–3277PubMedCrossRef De Becker P, Roeykens J, Reynders M, McGregor N, De Meirleir K (2000) Exercise capacity in chronic fatigue syndrome. Arch Intern Med 160(21):3270–3277PubMedCrossRef
15.
go back to reference Fulcher KY, White PD (2000) Strength and physiological response to exercise in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 69(3):302–307PubMedCrossRef Fulcher KY, White PD (2000) Strength and physiological response to exercise in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 69(3):302–307PubMedCrossRef
16.
go back to reference Bazelmans E, Bleijenberg G, Van Der Meer JW, Folgering H (2001) Is physical deconditioning a perpetuating factor in chronic fatigue syndrome? A controlled study on maximal exercise performance and relations with fatigue, impairment and physical activity. Psychol Med 31(1):107–114PubMedCrossRef Bazelmans E, Bleijenberg G, Van Der Meer JW, Folgering H (2001) Is physical deconditioning a perpetuating factor in chronic fatigue syndrome? A controlled study on maximal exercise performance and relations with fatigue, impairment and physical activity. Psychol Med 31(1):107–114PubMedCrossRef
17.
go back to reference Cook DB, Nagelkirk PR, Peckerman A, Poluri A, Lamanca JJ, Natelson BH (2003) Perceived exertion in fatiguing illness: civilians with chronic fatigue syndrome. Med Sci Sports Exerc 35(4):563–568PubMedCrossRef Cook DB, Nagelkirk PR, Peckerman A, Poluri A, Lamanca JJ, Natelson BH (2003) Perceived exertion in fatiguing illness: civilians with chronic fatigue syndrome. Med Sci Sports Exerc 35(4):563–568PubMedCrossRef
18.
go back to reference Cook DB, Nagelkirk PR, Peckerman A, Poluri A, Lamanca JJ, Natelson BH (2003) Perceived exertion in fatiguing illness: Gulf War veterans with chronic fatigue syndrome. Med Sci Sports Exerc 35(4):569–574PubMedCrossRef Cook DB, Nagelkirk PR, Peckerman A, Poluri A, Lamanca JJ, Natelson BH (2003) Perceived exertion in fatiguing illness: Gulf War veterans with chronic fatigue syndrome. Med Sci Sports Exerc 35(4):569–574PubMedCrossRef
19.
go back to reference Nagelkirk PR, Cook DB, Peckerman A et al (2003) Aerobic capacity of Gulf War veterans with chronic fatigue syndrome. Mil Med 168(9):750–755PubMed Nagelkirk PR, Cook DB, Peckerman A et al (2003) Aerobic capacity of Gulf War veterans with chronic fatigue syndrome. Mil Med 168(9):750–755PubMed
20.
go back to reference van’t Leven M, Zielhuis G, Avan der Meer JW, Verbeek AL, Bleijenberg G (2010) Fatigue and chronic fatigue syndrome-like complaints in the general population. Eur J Public Health 20(3):251–257PubMedCrossRef van’t Leven M, Zielhuis G, Avan der Meer JW, Verbeek AL, Bleijenberg G (2010) Fatigue and chronic fatigue syndrome-like complaints in the general population. Eur J Public Health 20(3):251–257PubMedCrossRef
21.
go back to reference Grant JE, Veldee MS, Buchwald D (1996) Analysis of dietary intake and selected nutrient concentrations in patients with chronic fatigue syndrome. J Am Diet Assoc 96(4):383–386PubMedCrossRef Grant JE, Veldee MS, Buchwald D (1996) Analysis of dietary intake and selected nutrient concentrations in patients with chronic fatigue syndrome. J Am Diet Assoc 96(4):383–386PubMedCrossRef
22.
go back to reference Heap LC, Peters TJ, Wessely S (1999) Vitamin B status in patients with chronic fatigue syndrome. J R Soc Med 92(4):183–185PubMed Heap LC, Peters TJ, Wessely S (1999) Vitamin B status in patients with chronic fatigue syndrome. J R Soc Med 92(4):183–185PubMed
23.
go back to reference Cox IM, Campbell MJ, Dowson D (1991) Red blood cell magnesium and chronic fatigue syndrome. Lancet 337(8744):757–760PubMedCrossRef Cox IM, Campbell MJ, Dowson D (1991) Red blood cell magnesium and chronic fatigue syndrome. Lancet 337(8744):757–760PubMedCrossRef
24.
go back to reference De Lorenzo F, Hargreaves J, Kakkar VV (1998) Phosphate diabetes in patients with chronic fatigue syndrome. Postgrad Med J 74(870):229–232PubMedCrossRef De Lorenzo F, Hargreaves J, Kakkar VV (1998) Phosphate diabetes in patients with chronic fatigue syndrome. Postgrad Med J 74(870):229–232PubMedCrossRef
25.
go back to reference Kuratsune H, Yamaguti K, Takahashi M, Misaki H, Tagawa S, Kitani T (1994) Acylcarnitine deficiency in chronic fatigue syndrome. Clin Infect Dis 18(Suppl 1):S62–S67PubMedCrossRef Kuratsune H, Yamaguti K, Takahashi M, Misaki H, Tagawa S, Kitani T (1994) Acylcarnitine deficiency in chronic fatigue syndrome. Clin Infect Dis 18(Suppl 1):S62–S67PubMedCrossRef
26.
go back to reference Plioplys AV, Plioplys S (1995) Serum levels of carnitine in chronic fatigue syndrome: clinical correlates. Neuropsychobiology 32(3):132–138PubMedCrossRef Plioplys AV, Plioplys S (1995) Serum levels of carnitine in chronic fatigue syndrome: clinical correlates. Neuropsychobiology 32(3):132–138PubMedCrossRef
27.
go back to reference Clague JE, Edwards RH, Jackson MJ (1992) Intravenous magnesium loading in chronic fatigue syndrome. Lancet 340(8811):124–125PubMedCrossRef Clague JE, Edwards RH, Jackson MJ (1992) Intravenous magnesium loading in chronic fatigue syndrome. Lancet 340(8811):124–125PubMedCrossRef
29.
go back to reference Kaslow JE, Rucker L, Onishi R (1989) Liver extract-folic acid-cyanocobalamin vs placebo for chronic fatigue syndrome. Arch Intern Med 149(11):2501–2503PubMedCrossRef Kaslow JE, Rucker L, Onishi R (1989) Liver extract-folic acid-cyanocobalamin vs placebo for chronic fatigue syndrome. Arch Intern Med 149(11):2501–2503PubMedCrossRef
30.
go back to reference Soetekouw PM, Wevers RA, Vreken P et al (2000) Normal carnitine levels in patients with chronic fatigue syndrome. Neth J Med 57(1):20–24PubMedCrossRef Soetekouw PM, Wevers RA, Vreken P et al (2000) Normal carnitine levels in patients with chronic fatigue syndrome. Neth J Med 57(1):20–24PubMedCrossRef
31.
go back to reference Goedendorp MM, Knoop H, Schippers GM, Bleijenberg G (2009) The lifestyle of patients with chronic fatigue syndrome and the effect on fatigue and functional impairments. J Hum Nutr Diet 22(3):226–231PubMedCrossRef Goedendorp MM, Knoop H, Schippers GM, Bleijenberg G (2009) The lifestyle of patients with chronic fatigue syndrome and the effect on fatigue and functional impairments. J Hum Nutr Diet 22(3):226–231PubMedCrossRef
32.
go back to reference Kim CH, Shin HC, Won CW (2005) Prevalence of chronic fatigue and chronic fatigue syndrome in Korea: community-based primary care study. J Korean Med Sci 20(4):529–534PubMedCrossRef Kim CH, Shin HC, Won CW (2005) Prevalence of chronic fatigue and chronic fatigue syndrome in Korea: community-based primary care study. J Korean Med Sci 20(4):529–534PubMedCrossRef
33.
go back to reference Yiu YM, Qiu MY (2005) A preliminary epidemiological study and discussion on traditional Chinese medicine pathogenesis of chronic fatigue syndrome in Hong Kong. Zhong Xi Yi Jie He Xue Bao 3(5):359–362PubMedCrossRef Yiu YM, Qiu MY (2005) A preliminary epidemiological study and discussion on traditional Chinese medicine pathogenesis of chronic fatigue syndrome in Hong Kong. Zhong Xi Yi Jie He Xue Bao 3(5):359–362PubMedCrossRef
34.
go back to reference Kawakami N, Iwata N, Fujihara S, Kitamura T (1998) Prevalence of chronic fatigue syndrome in a community population in Japan. Tohoku J Exp Med 186(1):33–41PubMedCrossRef Kawakami N, Iwata N, Fujihara S, Kitamura T (1998) Prevalence of chronic fatigue syndrome in a community population in Japan. Tohoku J Exp Med 186(1):33–41PubMedCrossRef
35.
go back to reference Masuda A, Nozoe SI, Matsuyama T, Tanaka H (1994) Psychobehavioral and immunological characteristics of adult people with chronic fatigue and patients with chronic fatigue syndrome. Psychosom Med 56(6):512–518PubMed Masuda A, Nozoe SI, Matsuyama T, Tanaka H (1994) Psychobehavioral and immunological characteristics of adult people with chronic fatigue and patients with chronic fatigue syndrome. Psychosom Med 56(6):512–518PubMed
36.
go back to reference Kawai K, Kawai A (1992) Studies on the relationship between chronic fatigue syndrome and Epstein–Barr virus in Japan. Intern Med 31(3):313–318PubMedCrossRef Kawai K, Kawai A (1992) Studies on the relationship between chronic fatigue syndrome and Epstein–Barr virus in Japan. Intern Med 31(3):313–318PubMedCrossRef
37.
go back to reference Hamaguchi M, Kojima T, Takeda N et al (2005) The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 143(10):722–728PubMed Hamaguchi M, Kojima T, Takeda N et al (2005) The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 143(10):722–728PubMed
38.
go back to reference Suzuki E, Yorifuji T, Ueshima K et al (2009) Sleep duration, sleep quality and cardiovascular disease mortality among the elderly: a population-based cohort study. Prev Med 49:135–141PubMedCrossRef Suzuki E, Yorifuji T, Ueshima K et al (2009) Sleep duration, sleep quality and cardiovascular disease mortality among the elderly: a population-based cohort study. Prev Med 49:135–141PubMedCrossRef
39.
go back to reference WW ZUNG (1965) A self-rating depression scale. Arch Gen Psychiatry 12:63–70 WW ZUNG (1965) A self-rating depression scale. Arch Gen Psychiatry 12:63–70
40.
go back to reference Fukuda K, Kobayashi S (1973) Seishin Shinkeigaku Zasshi 75:673–679PubMed Fukuda K, Kobayashi S (1973) Seishin Shinkeigaku Zasshi 75:673–679PubMed
41.
go back to reference Aaron DJ, Kriska AM, Dearwater SR, Cauley JA, Metz KF, LaPorte RE (1995) Reproducibility and validity of an epidemiologic questionnaire to assess past year physical activity in adolescents. Am J Epidemiol 142(2):191–201PubMed Aaron DJ, Kriska AM, Dearwater SR, Cauley JA, Metz KF, LaPorte RE (1995) Reproducibility and validity of an epidemiologic questionnaire to assess past year physical activity in adolescents. Am J Epidemiol 142(2):191–201PubMed
42.
go back to reference Yoshiike N, Matsumura Y, Zaman MM, Yamaguchi M (1998) Descriptive epidemiology of body mass index in Japanese adults in a representative sample from the National Nutrition Survey 1990–1994. Int J Obes Relat Metab Disord 22(7):684–687PubMedCrossRef Yoshiike N, Matsumura Y, Zaman MM, Yamaguchi M (1998) Descriptive epidemiology of body mass index in Japanese adults in a representative sample from the National Nutrition Survey 1990–1994. Int J Obes Relat Metab Disord 22(7):684–687PubMedCrossRef
43.
go back to reference Lockley SW, Skene DJ, Arendt J (1999) Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. J Sleep Res 8(3):175–183PubMedCrossRef Lockley SW, Skene DJ, Arendt J (1999) Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. J Sleep Res 8(3):175–183PubMedCrossRef
44.
go back to reference Ohayon MM (2002) Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6(2):97–111PubMedCrossRef Ohayon MM (2002) Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6(2):97–111PubMedCrossRef
45.
go back to reference Wu T, Willett WC, Hankinson SE, Giovannucci E (2005) Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diab Care 28(6):1390–1396CrossRef Wu T, Willett WC, Hankinson SE, Giovannucci E (2005) Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diab Care 28(6):1390–1396CrossRef
46.
go back to reference Dittner AJ, Wessely SC, Brown RG (2004) The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res 56(2):157–170PubMedCrossRef Dittner AJ, Wessely SC, Brown RG (2004) The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res 56(2):157–170PubMedCrossRef
47.
go back to reference Kroenke K, Wood DR, Mangelsdorff AD, Meier NJ, Powell JB (1988) Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. JAMA 260(7):929–934PubMedCrossRef Kroenke K, Wood DR, Mangelsdorff AD, Meier NJ, Powell JB (1988) Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. JAMA 260(7):929–934PubMedCrossRef
48.
go back to reference Lloyd AR (1990) Muscle versus brain: chronic fatigue syndrome. Med J Aust 153(9):530–534PubMed Lloyd AR (1990) Muscle versus brain: chronic fatigue syndrome. Med J Aust 153(9):530–534PubMed
49.
go back to reference Bates DW, Schmitt W, Buchwald D et al (1993) Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med 153(24):2759–2765PubMedCrossRef Bates DW, Schmitt W, Buchwald D et al (1993) Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med 153(24):2759–2765PubMedCrossRef
50.
go back to reference Daugherty SA, Henry BE, Peterson DL, Swarts RL, Bastien S, Thomas RS (1991) Chronic fatigue syndrome in northern Nevada. Rev Infect Dis 13(Suppl 1):S39–S44PubMedCrossRef Daugherty SA, Henry BE, Peterson DL, Swarts RL, Bastien S, Thomas RS (1991) Chronic fatigue syndrome in northern Nevada. Rev Infect Dis 13(Suppl 1):S39–S44PubMedCrossRef
51.
go back to reference Levine PH (1994) Epidemic neuromyasthenia and chronic fatigue syndrome: epidemiological importance of a cluster definition. Clin Infect Dis 18(Suppl 1):S16–S20PubMedCrossRef Levine PH (1994) Epidemic neuromyasthenia and chronic fatigue syndrome: epidemiological importance of a cluster definition. Clin Infect Dis 18(Suppl 1):S16–S20PubMedCrossRef
52.
go back to reference Briggs NC, Levine PH (1994) A comparative review of systemic and neurological symptomatology in 12 outbreaks collectively described as chronic fatigue syndrome, epidemic neuromyasthenia, and myalgic encephalomyelitis. Clin Infect Dis 18(Suppl 1):S32–S42PubMedCrossRef Briggs NC, Levine PH (1994) A comparative review of systemic and neurological symptomatology in 12 outbreaks collectively described as chronic fatigue syndrome, epidemic neuromyasthenia, and myalgic encephalomyelitis. Clin Infect Dis 18(Suppl 1):S32–S42PubMedCrossRef
53.
go back to reference Harvey SB, Wadsworth M, Wessely S, Hotopf M (2008) Etiology of chronic fatigue syndrome: testing popular hypotheses using a national birth cohort study. Psychosom Med 70(4):488–495PubMedCrossRef Harvey SB, Wadsworth M, Wessely S, Hotopf M (2008) Etiology of chronic fatigue syndrome: testing popular hypotheses using a national birth cohort study. Psychosom Med 70(4):488–495PubMedCrossRef
54.
go back to reference Schur E, Afari N, Goldberg J, Buchwald D, Sullivan PF (2007) Twin analyses of fatigue. Twin Res Hum Genet 10(5):729–733PubMedCrossRef Schur E, Afari N, Goldberg J, Buchwald D, Sullivan PF (2007) Twin analyses of fatigue. Twin Res Hum Genet 10(5):729–733PubMedCrossRef
55.
go back to reference Majer M, Jones JF, Unger ER et al (2007) Perception versus polysomnographic assessment of sleep in CFS and non-fatigued control subjects: results from a population-based study. BMC Neurol 7:40PubMedCrossRef Majer M, Jones JF, Unger ER et al (2007) Perception versus polysomnographic assessment of sleep in CFS and non-fatigued control subjects: results from a population-based study. BMC Neurol 7:40PubMedCrossRef
56.
go back to reference Neu D, Cappeliez B, Hoffmann G, Verbanck P, Linkowski P, Le Bon O (2009) High slow-wave sleep and low-light sleep: chronic fatigue syndrome is not likely to be a primary sleep disorder. J Clin Neurophysiol 26(3):207–212PubMedCrossRef Neu D, Cappeliez B, Hoffmann G, Verbanck P, Linkowski P, Le Bon O (2009) High slow-wave sleep and low-light sleep: chronic fatigue syndrome is not likely to be a primary sleep disorder. J Clin Neurophysiol 26(3):207–212PubMedCrossRef
Metadata
Title
Characteristics of chronic fatigue syndrome in a Japanese community population
Chronic fatigue syndrome in Japan
Authors
Masahide Hamaguchi
Yutaka Kawahito
Noriyuki Takeda
Takahiro Kato
Takao Kojima
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 7/2011
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-011-1702-9

Other articles of this Issue 7/2011

Clinical Rheumatology 7/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.